343 related articles for article (PubMed ID: 16766477)
1. Degradation of organophosphorus neurotoxicity in SY5Y neuroblastoma cells by organophosphorus hydrolase (OPH).
Cho TM; Wild JR; Donnelly KC; Tiffany-Castiglioni E
J Toxicol Environ Health A; 2006 Aug; 69(15):1413-29. PubMed ID: 16766477
[TBL] [Abstract][Full Text] [Related]
2. Neurofilament 200 as an indicator of differences between mipafox and paraoxon sensitivity in Sy5Y neuroblastoma cells.
Cho T; Tiffany-Castiglioni E
J Toxicol Environ Health A; 2004 Jul; 67(13):987-1000. PubMed ID: 15205030
[TBL] [Abstract][Full Text] [Related]
3. Neurotoxicity induced in differentiated SK-N-SH-SY5Y human neuroblastoma cells by organophosphorus compounds.
Hong MS; Hong SJ; Barhoumi R; Burghardt RC; Donnelly KC; Wild JR; Venkatraj V; Tiffany-Castiglioni E
Toxicol Appl Pharmacol; 2003 Jan; 186(2):110-8. PubMed ID: 12639502
[TBL] [Abstract][Full Text] [Related]
4. In vitro study of the neuropathic potential of the organophosphorus compounds fenamiphos and profenofos: Comparison with mipafox and paraoxon.
Emerick GL; Fernandes LS; de Paula ES; Barbosa F; dos Santos NA; dos Santos AC
Toxicol In Vitro; 2015 Aug; 29(5):1079-87. PubMed ID: 25910916
[TBL] [Abstract][Full Text] [Related]
5. High concentration of trichlorfon (1mM) disrupts axonal cytoskeleton and decreases the expression of plasticity-related proteins in SH-SY5Y cells.
Fernandes LS; Emerick GL; Ferreira RS; Santos NAGD; Santos ACD
Toxicol In Vitro; 2017 Mar; 39():84-92. PubMed ID: 27939611
[TBL] [Abstract][Full Text] [Related]
6. Acetylcholinesterase and neuropathy target esterase inhibitions in neuroblastoma cells to distinguish organophosphorus compounds causing acute and delayed neurotoxicity.
Ehrich M; Correll L; Veronesi B
Fundam Appl Toxicol; 1997 Jul; 38(1):55-63. PubMed ID: 9268605
[TBL] [Abstract][Full Text] [Related]
7. Hydrolyzing activities of phenyl valerate sensitive to organophosphorus compounds paraoxon and mipafox in human neuroblastoma SH-SY5Y cells.
González-González M; Estévez J; Del Río E; Vilanova E; Sogorb MA
Toxicology; 2018 Aug; 406-407():123-128. PubMed ID: 30118792
[TBL] [Abstract][Full Text] [Related]
8. In vitro study of the neuropathic potential of the organophosphorus compounds trichlorfon and acephate.
Fernandes LS; Emerick GL; dos Santos NA; de Paula ES; Barbosa F; dos Santos AC
Toxicol In Vitro; 2015 Apr; 29(3):522-8. PubMed ID: 25596135
[TBL] [Abstract][Full Text] [Related]
9. Bovine chromaffin cell cultures as model to study organophosporus neurotoxicity.
Quesada E; Sogorb MA; Vilanova E; Carrera V
Toxicol Lett; 2004 Jun; 151(1):163-70. PubMed ID: 15177651
[TBL] [Abstract][Full Text] [Related]
10. Effects of organophosphorus compounds on ATP production and mitochondrial integrity in cultured cells.
Massicotte C; Knight K; Van der Schyf CJ; Jortner BS; Ehrich M
Neurotox Res; 2005; 7(3):203-17. PubMed ID: 15897155
[TBL] [Abstract][Full Text] [Related]
11. Interaction of organophosphorus compounds with muscarinic receptors in SH-SY5Y human neuroblastoma cells.
Ehrich M; Intropido L; Costa LG
J Toxicol Environ Health; 1994 Sep; 43(1):51-63. PubMed ID: 8078092
[TBL] [Abstract][Full Text] [Related]
12. L- and T-type calcium channel blockers protect against the inhibitory effects of mipafox on neurite outgrowth and plasticity-related proteins in SH-SY5Y cells.
Fernandes LS; Dos Santos NAG; Emerick GL; Santos ACD
J Toxicol Environ Health A; 2017; 80(19-21):1086-1097. PubMed ID: 28862523
[TBL] [Abstract][Full Text] [Related]
13. Discrimination of carboxylesterases of chicken neural tissue by inhibition with a neuropathic, non-neuropathic organophosphorus compounds and neuropathy promoter.
Céspedes MV; Escudero MA; Barril J; Sogorb MA; Vicedo JL; Vilanova E
Chem Biol Interact; 1997 Oct; 106(3):191-200. PubMed ID: 9413546
[TBL] [Abstract][Full Text] [Related]
14. Effects of mipafox, paraoxon, chlorpyrifos and its metabolite chlorpyrifos-oxon on the expression of biomarker genes of differentiation in D3 mouse embryonic stem cells.
Sogorb MA; Fuster E; Del Río E; Estévez J; Vilanova E
Chem Biol Interact; 2016 Nov; 259(Pt B):368-373. PubMed ID: 27117976
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of carboxylesterases in SH-SY5Y human and NB41A3 mouse neuroblastoma cells by organophosphorus esters.
Ehrich M; Correll L
J Toxicol Environ Health A; 1998 Mar; 53(5):385-99. PubMed ID: 9515941
[TBL] [Abstract][Full Text] [Related]
16. Modification of mipafox-induced inhibition of neuropathy target esterase in neuroblastoma cells of human origin.
Nostrandt AC; Ehrich M
Toxicol Appl Pharmacol; 1993 Jul; 121(1):36-42. PubMed ID: 8337699
[TBL] [Abstract][Full Text] [Related]
17. Reduction of neuropathy target esterase does not affect neuronal differentiation, but moderate expression induces neuronal differentiation in human neuroblastoma (SK-N-SH) cell line.
Chang PA; Chen R; Wu YJ
Brain Res Mol Brain Res; 2005 Nov; 141(1):30-8. PubMed ID: 16122834
[TBL] [Abstract][Full Text] [Related]
18. Comparative non-cholinergic neurotoxic effects of paraoxon and diisopropyl fluorophosphate (DFP) on human neuroblastoma and astrocytoma cell lines.
Qian Y; Venkatraj J; Barhoumi R; Pal R; Datta A; Wild JR; Tiffany-Castiglioni E
Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):162-71. PubMed ID: 17223147
[TBL] [Abstract][Full Text] [Related]
19. Avian embryonic brain reaggregate culture system. II. NTE activity discriminates between effects of a single neuropathic or nonneuropathic organophosphorus compound exposure.
Funk KA; Liu CH; Higgins RJ; Wilson BW
Toxicol Appl Pharmacol; 1994 Jan; 124(1):159-63. PubMed ID: 8291056
[TBL] [Abstract][Full Text] [Related]
20. Genomic and phenotypic alterations of the neuronal-like cells derived from human embryonal carcinoma stem cells (NT2) caused by exposure to organophosphorus compounds paraoxon and mipafox.
Pamies D; Sogorb MA; Fabbri M; Gribaldo L; Collotta A; Scelfo B; Vilanova E; Harris G; Bal-Price A
Int J Mol Sci; 2014 Jan; 15(1):905-26. PubMed ID: 24413757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
